Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Jean Michon"'
Publikováno v:
Pediatric Blood & Cancer
Autor:
Michel Zerah, Louise Galmiche-Rolland, Hervé Brisse, Luc Joyeux, Sabine Irtan, Christophe Glorion, Jean Michon, Caroline Harte, Sabine Sarnacki, Timothé de Saint Denis, Luca Pio, T. Odent, Dominique Valteau-Couanet, Thomas Blanc
Publikováno v:
Pediatric Blood & Cancer. 66
INTRODUCTION: Prognosis of dumbbell neuroblastoma (NBL) is mainly determined by the sequelae induced by the tumor itself and the neurosurgical approach. However, after primary chemotherapy, surgical management of the residual tumor, especially the sp
Autor:
Sabine Irtan, Chloé Le Cossec, Sabine Sarnacki, Jean Michon, Gudrun Schleiermacher, Louise Galmiche-Rolland, Hervé Brisse, Sandra Canale, Caroline Elie, Dominique Valteau-Couanet, Veronique Minard-Colin
Publikováno v:
Pediatric Blood & Cancer. 62:1543-1549
Background Patients with neuroblastoma are now stratified at diagnosis according to the presence and number of image-defined risk factors (IDRFs). We examined the added value of IDRF assessment after neoadjuvant chemotherapy for predicting surgical r
Autor:
Keith Holmes, Bruno De Bernardi, Tom Monclair, Véronique Mosseri, Jean Michon, Giovanni Cecchetto
Publikováno v:
Pediatric Blood & Cancer. 62:1536-1542
Background The European multicenter study LNESG1 was designed to evaluate the safety and efficacy of surgical treatment alone in patients with localised neuroblastoma. In a retrospective, observational study we examined the impact of image-defined ri
Autor:
Jean Michon, Daniel Orbach, Antoine Italiano, C. Guillemet, Sarah Cohen-Gogo, Gaëlle Pierron, Valérie Laurence, Jean-Michel Coindre, Olivier Delattre, Laurence Brugières, Véronique Mosseri, Cécile Cellier
Publikováno v:
Pediatric Blood & Cancer. 61:2191-2198
Background This retrospective multicenter study assessed the clinical, radiological and pathological presentation, treatment and outcome of 26 patients with Ewing-like sarcoma harboring BCOR-CCNB3 gene fusion transcript. Tumor samples had been collec
Autor:
Paul Fréneaux, Pascale Philippe-Chomette, Jean Michon, Yvan de la Monneraye, Hervé Brisse, Franck Bourdeaut, Gudrun Schleiermacher, Aurore Coulomb, Isabelle Aerts, Hélène Pacquement, Jean-Michel Zucker, Jerzy Klijanienko, Dominique Berrebi, Georges Audry, Daniel Orbach, Sabine Sarnacki, Francois P. Doz
Publikováno v:
Pediatric Blood & Cancer. 66:e27641
Objectives According to the Renal Tumor Study Group (RTSG) of the International Society of Paediatric Oncology (SIOP), diagnostic biopsy of renal tumors prior to neoadjuvant chemotherapy is not mandatory unless the presentation is atypical for a Wilm
Autor:
Stéphane Ducassou, Jeanine Bouzy, Christophe Bergeron, Carole Coze, Olivier Hartmann, Dominique Plantaz, Hervé Rubie, Jean Michon, Dominique Valteau-Couanet, Gwénaël Le Teuff, Pascal Chastagner, Nicolas Sirvent, Marie-Cécile Le Deley
Publikováno v:
Pediatric Blood & Cancer. 61:977-981
Background To evaluate long-term survival of the first cohort of stage-4 neuroblastoma patients treated with the N7 induction chemotherapy, surgery of the primary tumor and high-dose chemotherapy (HDC) containing Busulfan–Melphalan (Bu-Mel) followe
Autor:
Sabine Sarnacki, Franck Bourdeaut, Liliane Boccon-Gibod, Daniel Orbach, Sylvie Rossignol, Isabelle Aerts, François Doz, Jean Michon, Marion Gauthier-Villars, Dominique Stoppa-Lyonnet, C Baumann, S Dumoucel, P Parisot, Pascale Philippe-Chomette, Hervé Brisse, Hélène Pacquement, Gudrun Schleiermacher
Publikováno v:
Pediatric Blood & Cancer. 61:140-144
Background Wilms Tumor (WT) can occur in association with tumor predisposition syndromes and/or with clinical malformations. These associations have not been fully characterized at a clinical and molecular genetic level. This study aims to describe c
Autor:
Aurore Surun, Daniel Orbach, Gudrun Schleiermacher, Irene Jiménez, Isabelle Aerts, Jean Michon, Jean-Claude K. Dupont, Marie-Eglantine Dujaric, Hélène Pacquement, François Doz, Franck Bourdeaut
Publikováno v:
Pediatric Blood & Cancer. 65:e26916
Background The European Paediatric Regulation was introduced in 2007 to facilitate access to new medicines for children. Our study explored accessibility of early-phase trials in pediatric oncology, in line with the European Paediatric Regulation, to
Autor:
Gudrun Schleiermacher, Olivier Delattre, Patricia de Cremoux, Véronique Mosseri, Carine Tran-Perennou, Pascale Fehlbaum, Jérôme Couturier, Jean Michon, Philippe Vielh, François Doz, Jerzy Klijanienko, Nathalie Jourdan-Da-Silva
Publikováno v:
Pediatric Blood & Cancer. 48:311-317
Background Neuroblastoma is a heterogeneous pediatric disease. Most patients with localized disease usually have a favorable prognosis, but patients with advanced disease have a poor prognosis despite combination chemotherapy. Treatment failure may b